The audit also found that the FDA sometimes failed to:
• conduct firm inspections or obtain complete information on the contaminated products;
• conduct timely or complete audit checks of consignees;
• review recall strategies and promptly issue notification letters to firms conveying the review results and other essential instructions; and
• witness the disposal of the products or obtain the required documentation showing that the products had been properly disposed of.